Compare Elevance Health Inc. (ELV) vs UnitedHealth Group Incorporated (UNH) Stock

Elevance Health Inc. (ELV) offers the better valuation at 12.7x trailing P/E (12.3x forward), making it the more compelling value choice. Analysts rate Elevance Health Inc. (ELV) a "Buy" — based on 37 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Elevance Health Inc. (ELV) is the cheapest at 12.7x versus UnitedHealth Group Incorporated at 18.8x. On forward P/E, Elevance Health Inc. is actually cheaper at 12.3x.

Over the past 5 years, Elevance Health Inc. (ELV) delivered a total return of +12.0%, compared to -1.5% for UnitedHealth Group Incorporated (UNH). A $10,000 investment in ELV five years ago would be worth approximately $11K today (assuming dividends reinvested). Over 10 years, the gap is even starker: UNH returned +191.5% versus ELV's +178.7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Elevance Health Inc. (ELV) is the lower-risk stock at 0.20β versus UnitedHealth Group Incorporated's 0.28β — meaning UNH is approximately 37% more volatile than ELV relative to the S&P 500. On balance sheet safety, Elevance Health Inc. (ELV) carries a lower debt/equity ratio of 73% versus 77% for UnitedHealth Group Incorporated — giving it more financial flexibility in a downturn.

UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 3.2% net margin versus 2.8% for Elevance Health Inc. — meaning it keeps 3.2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4.2% versus 3.5% for ELV. At the gross margin level — before operating expenses — ELV leads at 56.2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Elevance Health Inc. (ELV) trades at 12.3x forward P/E versus 16.4x for UnitedHealth Group Incorporated — 4.1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UNH: 31.4% to $385.38.

All stocks in this comparison pay dividends. UnitedHealth Group Incorporated (UNH) offers the highest yield at 5.2%, versus 2.2% for Elevance Health Inc. (ELV).

For long-horizon retirement investors, Elevance Health Inc. (ELV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.20), 2.2% yield, +178.7% 10Y return). Both have compounded well over 10 years (ELV: +178.7%, UNH: +191.5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. In terms of investment character: ELV is a mid-cap deep-value stock; UNH is a large-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.